RAB10 rs142787485: What Your Genotype Means for AD Resilience
The rs142787485 variant is a rare genetic change located in the RAB10 gene. Research suggests that individuals carrying the G allele may exhibit a degree of resilience against the development of Alzheimer's disease.
What each genotype means
Typical risk profile
This is the most common genotype for this variant. Research indicates that individuals with this genotype do not carry the specific genetic variation associated with potential resilience against Alzheimer's disease.
This is the most frequent genotype observed in the general population.
Potential resilience association
Carrying one copy of the G allele has been associated in some studies with a reduced statistical risk of developing Alzheimer's disease. This association is primarily observed in individuals who may otherwise be at higher risk for the condition, though the exact protective mechanism remains a subject of ongoing research.
This genotype is relatively rare in the general population.
Potential resilience association
Carrying two copies of the G allele has been associated in some studies with a reduced statistical risk of developing Alzheimer's disease. While this variant is identified as a potential resilience locus, it is not a diagnostic indicator, and individuals should consult with a healthcare professional regarding their overall risk profile.
This genotype is very rare in the general population.
Understanding the rs142787485 Variant
The rs142787485 variant is a single nucleotide polymorphism (SNP) situated within the 3'-untranslated region (3'-UTR) of the RAB10 gene on chromosome 2. In genetics, a 3'-UTR is a section of messenger RNA that follows the coding region and plays a critical role in regulating gene expression, including the stability and translation of the mRNA into protein. Because this variant is located in a regulatory region rather than the protein-coding sequence itself, it is thought to influence how much RAB10 protein is produced in the cell. Scientists identified this specific variant through whole-genome sequencing studies focused on individuals who remained cognitively healthy despite having other high-risk genetic factors for Alzheimer's disease. By studying these 'resilient' individuals, researchers aim to uncover protective mechanisms that might one day inform therapeutic strategies.
The Role of the RAB10 Gene
The RAB10 gene encodes a member of the RAS oncogene family, which are small GTPase proteins. These proteins act as molecular switches that regulate intracellular membrane trafficking, helping to move materials between different compartments within a cell. In the context of neurobiology, RAB10 is involved in the trafficking of the amyloid precursor protein (APP). Proper regulation of APP is essential, as its processing can lead to the production of amyloid-beta peptides, which are known to accumulate in the brains of individuals with Alzheimer's disease. Studies have indicated that RAB10 expression is often elevated in the brains of patients with Alzheimer's. By reducing the expression of RAB10, the rs142787485 variant may help modulate the processing of APP, potentially lowering the ratio of amyloid-beta 42 to 40, which is considered a key marker of Alzheimer's pathology.
Evidence and Statistical Associations
The association between rs142787485 and Alzheimer's disease is categorized as having moderate evidence strength. Initial research, such as the study conducted by Ridge et al., identified this variant in high-risk pedigrees and observed that carriers of the G allele showed a significant reduction in the odds of developing Alzheimer's disease. Specifically, some cohorts reported odds ratios ranging from approximately 0.58 to 0.69 for G allele carriers compared to non-carriers. While these findings are statistically significant within the studied groups, it is important to note that this is a rare variant. The evidence is grounded in observational studies of specific cohorts, and while the biological link to APP metabolism provides a plausible mechanism for resilience, further large-scale, diverse population studies are required to confirm the consistency and magnitude of this protective effect across different ancestral backgrounds.
Interpreting Your Genetic Information
It is vital to understand that genetic variants like rs142787485 do not determine a person's health destiny. Alzheimer's disease is a complex, multifactorial condition influenced by a combination of genetics, lifestyle, and environmental factors. Having a 'protective' variant does not guarantee immunity from the disease, nor does the absence of it mean one will certainly develop it. This information is currently used primarily in research settings to understand the biological pathways of disease resilience. Consumers should not use this information to make medical decisions or to self-diagnose. If you have concerns about cognitive health or your family history, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can provide context based on your full clinical picture and help you understand the limitations of current genetic testing.
How common is this variant?
The rs142787485 variant is considered rare, and specific population frequency data across diverse global ancestries is not widely documented in standard public databases.
Frequently asked questions
Does having the G allele mean I will not get Alzheimer's?
No. The G allele is associated with a statistical reduction in risk within certain research cohorts, but it does not provide immunity. Alzheimer's disease is influenced by many factors, and this variant is only one small piece of a very complex puzzle.
Is this a diagnostic test for Alzheimer's?
No, this is not a diagnostic test. Genetic variants are used in research to understand disease mechanisms, but they are not used to predict individual clinical outcomes or diagnose Alzheimer's disease.
Where can I get tested for this variant?
This variant is typically only analyzed in specialized research studies or comprehensive whole-genome sequencing projects. It is not part of standard clinical diagnostic panels for Alzheimer's disease.
What should I do if I know my genotype for this SNP?
You should discuss any concerns about your cognitive health with your primary care physician or a neurologist. Do not use genetic information to make changes to your health management without professional medical guidance.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs142787485?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29